Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effect Of Deproteinization On The Performance Of CPP-ACPF On Hypomineralized Enamel
NCT07653373Not yet recruiting
- Sponsor
- Universidade Ceuma
- Start
- Aug 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised, double-blind trial of casein phosphopeptide-amorphous calcium phosphate + fluoride in Molar incisor hypomineralization (MIH) (3 arms), sponsored by Universidade Ceuma. Primary endpoint: Mineralization of Molar Incisor Hypomineralization lesions at 1 month. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
casein phosphopeptide-amorphous calcium phosphate + fluoride
03
Conditions
Molar incisor hypomineralization (MIH)
Beyond the preview
Go deeper on NCT07653373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07653373.